The end of 2017 is peppered with serialization compliance deadlines for the pharma industry as it continues in the combat against counterfeit medicines.
This report discusses:
- About the Respondents
- Findings (Planning, Implementation Progress, etc.)
- Closing Remarks
Want to read the entire article?
Sign up for our monthly newsletters and receive exclusive news, whitepapers, and more about the Pharmaceutical and Healthcare industry!